Medlab Clinical Limited (ASX:MDC) Announces Q2 2025 Business Update
Medlab Clinical Limited (ASX:MDC) announces Q2 2025 business update, including AGM plans and ASX removal, with a closing cash balance of $5K.
Medlab Clinical Limited (ASX:MDC) announces Q2 2025 business update, including AGM plans and ASX removal, with a closing cash balance of $5K.
Redivium Limited (ASX:RIL) successfully issues EUR 25 million green bonds to fund sustainable battery recycling initiatives across Europe.
Fisher & Paykel Healthcare (ASX:FPH) addresses new US tariffs, detailing cost projections for 2026 and future strategies.
Lithium Energy Limited (ASX:LEL) amends the sale of its Solaroz project and plans to spin out Axon Graphite through a shareholder-approved IPO.
Echo IQ Limited (ASX:EIQ) submits a pre-submission meeting request with the US FDA for its heart failure solution, EchoSolv HF, progressing towards market entry in H2 2025.
Saferoads Holdings Limited (ASX:SRH) reports a slight revenue decrease in Q4, significant debt reduction, and progress on business sale and product approvals.
Conico Ltd (ASX:CNJ) releases December 2024 Quarterly Report, detailing project updates and legal disputes.
Alchemy Resources Limited (ASX:ALY) reports a quarterly net cash outflow of $15,000 in operating activities and $533,000 in investing activities, ending the quarter with $2.003 million in cash.
Renascor (ASX:RNU) reports significant progress on BAM and PSG projects, exceeds production targets, and extends Major Project Status.
NuCoal Resources Ltd (ASX:NCR) criticises the NSW Premier’s refusal of compensation related to the Mining Amendment Act and plans to seek further actions.